CReATe podcast

Artwork

CReATe Connect Fitness

Player FM - Internet Radio Done Right

Hozzáadva hét éve

A tartalmat a CReATe Consortium biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a CReATe Consortium vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.

P

Peak Travel

Peak Travel podcast artwork

Peak Travel podcast artwork

1
You Can Visit All Seven Continents. But Should You? 26:46

13 napja26:46

Lejátszás később

Lejátszás később

26:46

For many travelers, Antarctica is a bucket-list destination, a once-in-a-lifetime opportunity to touch all seven continents. In 2023, a record-breaking 100,000 tourists made the trip. But the journey begs a fundamental question: What do we risk by traveling to a place that is supposed to be uninhabited by humans? And as the climate warms, should we really be going to Antarctica in the first place? SHOW NOTES: Kara Weller: The Impossible Dilemma of a Polar Guide Marilyn Raphael: A twenty-first century structural change in Antarctica’s sea ice system Karl Watson: First Time in Antarctica Jeb Brooks : 7 Days in Antarctica (Journey to the South Pole) Metallica - Freeze 'Em All: Live in Antarctica Learn about your ad choices: dovetail.prx.org/ad-choices…

CReATe Podcast

Megosztás

Sorozat kép•Feed

A tartalmat a CReATe Consortium biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a CReATe Consortium vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.

CReATe Connect podcasts are short recorded interviews on topics we hope will be of interest to patients with ALS and other motor neuron diseases.

… continue reading

75 epizódok

#CReATe Connect #Fitness

Artwork

CReATe Podcast

updated körülbelül egy éve

Megosztás

Sorozat kép•Feed

A tartalmat a CReATe Consortium biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a CReATe Consortium vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.

CReATe Connect podcasts are short recorded interviews on topics we hope will be of interest to patients with ALS and other motor neuron diseases.

… continue reading

75 epizódok

#CReATe Connect #Fitness

Alle episoder

×

C

CReATe Podcast

CReATe Podcast podcast artwork

1
CReATe Author Series Ep. 13 - Dr. Benatar on Prognostic Markers and ALS 26:31

9 weeks26:31

Lejátszás később

Lejátszás később

26:31

Dr. Michael Benatar is a Professor of Neurology and Chief of the Neuromuscular Division and Executive Director of the ALS Center at the University of Miami. Here he discusses the recent publication “Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis”.…

C

CReATe Podcast

CReATe Podcast podcast artwork

1
CReATe Author Series Ep. 12 - Drs. Jesse Crayle and Evadnie Rampersaud on Genetics and ALS Reversal Phenotype 26:28

16 weeks26:28

Lejátszás később

Lejátszás később

26:28

Dr. Jesse Crayle is a clinical neuromuscular fellow in the Department of Neurology at Washington University in St. Louis and Dr. Evadnie Rampersaud is a Principal Bioinformatics Research Scientist at St. Jude Children’s Research Hospital. They will be discussing their publication “Genetic Associations With an Amyotrophic Lateral Sclerosis Reversal Phenotype.”…

C

CReATe Podcast

CReATe Podcast podcast artwork

1
ALS Untangled Series Ep. 60 - Nuedexta 24:58

20 weeks24:58

Lejátszás később

Lejátszás később

24:58

Nuedexta is a combination of dextromethorphan and quinidine, and is FDA approved for treating “pseudobulbar affect” (a symptom complex where patients lose control of their laughing and crying). Here we summarize recent trials suggesting that Nuedexta might also help bulbar function (speech, swallowing and oral secretions). We also discuss important risks, monitoring, and insurance coverage.…

C

CReATe Podcast

CReATe Podcast podcast artwork

1
ALS Untangled Series Ep. 59 - Lions Mane 17:11

24 weeks17:11

Lejátszás később

Lejátszás később

17:11

Lions Mane is a mushroom that has neuroprotective, neurotrophic, antioxidant, and anti-inflammatory properties. Here we review what is known about its use in ALS models as well as patients living with the disease.

C

CReATe Podcast

CReATe Podcast podcast artwork

1
ALS Untangled Series Ep. 58 - Insulin 19:31

29 weeks19:31

Lejátszás később

Lejátszás később

19:31

Insulin is a hormone most commonly used to lower blood sugar in people with diabetes. Here we talk about some theoretical ways it might help help people with ALS, as well as the lack of convincing case reports or trials and the risks.

C

CReATe Podcast

CReATe Podcast podcast artwork

1
ALS Untangled Series Ep. 57 - Caffeine 21:43

33 weeks21:43

Lejátszás később

Lejátszás később

21:43

Caffeine is a chemical most of us ingest every day. In addition to its stimulant properties, there are some theoretical ways it could help slow ALS progression. Here we discuss the contradictory pre-clinical models and the lack of a convincing relationship between caffeine intake and ALS progression in natural history studies.…

C

CReATe Podcast

CReATe Podcast podcast artwork

1
CReATe Author Series Ep. 11 - Dr. Benatar and the Miami Framework for ALS 30:07

36 weeks30:07

Lejátszás később

Lejátszás később

30:07

Michael Benatar is a Professor of Neurology and Chief of the Neuromuscular Division and Executive Director of the ALS Center at the University of Miami. Here he discusses the recent publication “The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology”.…

C

CReATe Podcast

CReATe Podcast podcast artwork

1
CReATe Author Series Ep. 10 - Drs. McHutchison and Benatar on Cognitive and Behavioral Changes in MND 29:51

1 year29:51

Lejátszás később

Lejátszás később

29:51

Dr. Caroline McHutchison is a Neuropsychologist and CReATe Clinical Research Scholar at the University of Edinburgh and Dr. Michael Benatar is a Professor of Neurology and Chief of the Neuromuscular Division and Executive Director of the ALS Center at the University of Miami. They will be discussing their recent publication “Temporal course of cognitive and behavioural changes in motor neuron diseases”.…

C

CReATe Podcast

CReATe Podcast podcast artwork

1
CReATe Author Series Ep. 9 - Drs. Heatwole and Benatar on Patient Reported Outcome Measures and ALS 36:02

1 year36:02

Lejátszás később

Lejátszás később

36:02

Dr. Chad Heatwole is a Professor of Neurology and the Director of the Center for Health and Technology at the University of Rochester Medical Center and Dr. Michael Benatar is a Professor of Neurology and Chief of the Neuromuscular Division and Executive Director of the ALS Center at the University of Miami. They will be discussing their recent publication “The amyotrophic lateral sclerosis-health index (ALS-HI): development and evaluation of a novel outcome measure” and its role as a patient reported outcome measure for ALS.…

C

CReATe Podcast

CReATe Podcast podcast artwork

1
ALS Untangled Series Ep. 56 - Sodium Chlorite 22:15

1 year22:15

Lejátszás később

Lejátszás később

22:15

Sodium chlorite is an experimental drug targeting macrophage activation. It exists in different formulations. An oral formulation has potentially deadly side effects. An IV formulation called NP001 has been in recent trials targeting a subset of people with ALS. Here we review the interesting development of this product and where we expect that to go in the near future.…

C

CReATe Podcast

CReATe Podcast podcast artwork

1
ALS Untangled Series Ep. 55 - Rituximab 12:38

2 years12:38

Lejátszás később

Lejátszás később

12:38

Rituximab is an intravenous product that reduces B lymphocytes. It can help improve strength in patients with myasthenia gravis and multi-focal motor neuropathy, neuromuscular diseases that are caused by circulating antibodies made by B lymphocytes. In this podcast we examine the possible use of rituximab to treat patients with ALS…

C

CReATe Podcast

CReATe Podcast podcast artwork

1
ALS Untangled Series Ep. 54 - Ozone Therapy 18:44

2 years18:44

Lejátszás később

Lejátszás később

18:44

Ozone is an oxidizing agent which has some surprisingly plausible mechanisms by which it could influence ALS progression. It can also be dangerous. The FDA has warned against using it as a treatment for any disease. Further studies are needed to determine whether there is any dose or route of administration that might be safe and effective for use in people with ALS.…

C

CReATe Podcast

CReATe Podcast podcast artwork

1
ALS Untangled Series Ep. 53 - Astaxanthin 20:42

2 years20:42

Lejátszás később

Lejátszás később

20:42

Astaxanthin is a naturally occurring chemical which has plausible mechanisms for treating ALS and appears reasonably safe and well tolerated in non-ALS trials. We look forward to ALS-specific trials planned later this year which should shed important light on whether this is specifically safe for people with ALS, and whether it really can slow ALS progression.…

C

CReATe Podcast

CReATe Podcast podcast artwork

1
CReATe Author Series Ep. 8 Part I - Drs. Turner and Benatar on Neurofilament Light Chain as Biomarker for ALS 20:32

2 years20:32

Lejátszás később

Lejátszás később

20:32

Dr. Martin Turner is a Professor of Clinical Neurology & Neurosciences at the University of Oxford and Dr. Michael Benatar is a Professor of Neurology and Chief of the Neuromuscular Division and Executive Director of the ALS Center at the University of Miami. They will be discussing their recent publication “Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal”, and the potential role of NfL as a biomarker for ALS. This is part I of a two part series.…

C

CReATe Podcast

CReATe Podcast podcast artwork

1
CReATe Author Series Ep. 8 Part II - Drs. Turner and Benatar on Neurofilament Light Chain as Biomarker for ALS 25:29

2 years25:29

Lejátszás később

Lejátszás később

25:29

Dr. Martin Turner is a Professor of Clinical Neurology & Neurosciences at the University of Oxford and Dr. Michael Benatar is a Professor of Neurology and Chief of the Neuromuscular Division and Executive Director of the ALS Center at the University of Miami. They will be discussing their recent publication “Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal”, and the potential role of NfL as a biomarker for ALS. This is part II of a two part series.…

Üdvözlünk a Player FM-nél!

A Player FM lejátszó az internetet böngészi a kiváló minőségű podcastok után, hogy ön élvezhesse azokat. Ez a legjobb podcast-alkalmazás, Androidon, iPhone-on és a weben is működik. Jelentkezzen be az feliratkozások szinkronizálásához az eszközök között.

Hallgasson 500+ témát

Hallgassa ezt a műsort, miközben felfedezi